EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A feasibility study of sexual organ‐dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three‐dimensional conformal radiation therapy

Margaret H Downes iD, Victoria Olsen, Andre Williams, Rendi Sheu, Maria Thor, Lucy Greenwald, Vishruta Dumane iD, Kristin Hsieh, Ayesha Ali, Orly Morgan, Michael Buckstein, Deborah C Marshall

Journal of Applied Clinical Medical Physics · 2025

DOI: 10.1002/acm2.70394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2025. Verfasst von Margaret H Downes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Radiotherapy, Intensity-Modulated, Organs at Risk, Radiotherapy Planning, Computer-Assisted, Rectal Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sexual dysfunction is a significant toxicity of pelvic radiation therapy (RT) for female rectal cancer patients and may be more common with intensity‐modulated techniques compared to three‐dimensional conformal radiation therapy (3D‐CRT). However, limited research has evaluated dose sparing of female sexual organs at risk (OARs), particularly erectile tissues that are critical for sexual function.

Purpose

This feasibility study aimed to demonstrate the practicality of contouring and sparing female sexual OARs in rectal cancer RT by generating sexual organ–sparing volumetric modulated arc therapy (SO‐VMAT) plans from a small 3D‐CRT cohort and comparing dose distributions to guide future planning.

Methods

Nine female patients with low rectal adenocarcinoma treated with concurrent chemoradiation using 3D‐CRT were retrospectively analyzed. Sexual OARs (bulboclitoris, external genitalia, and vagina) were contoured and incorporated into replanned SO‐VMAT plans. Institutional dose–volume constraints were applied for standard OARs and planning target volumes (PTVs). SO‐VMAT and 3D‐CRT plans were normalized to equal PTV coverage, and dose–volume metrics were compared using Wilcoxon signed‐rank tests.

Results

Contouring and sparing of female sexual OARs was feasible in all cases. Compared to 3D‐CRT, SO‐VMAT reduced radiation doses to sexual OARs. For the bulboclitoris, SO‐VMAT lowered V3000cGy and V4000cGy (both p = 0.02). For the external genitalia, SO‐VMAT reduced maximum and mean dose (both p = 0.02) as well as V1000cGy ( p = 0.004) and V2000cGy ( p = 0.01). Vaginal sparing was observed at V4000cGy ( p = 0.03). SO‐VMAT provided significant bladder sparing, whereas bowel and femoral head doses remained comparable. Target coverage remained equivalent between techniques.

Conclusion

This study demonstrates that female sexual OARs can be systematically contoured and effectively spared during rectal cancer RT using SO‐VMAT. Compared with 3D‐CRT, SO‐VMAT achieved meaningful dose reductions while maintaining target coverage. These preliminary findings support multi‐institutional studies with patient‐reported outcomes to validate clinical relevance and guide integration of female sexual OARs into treatment planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiotherapy, Intensity-ModulatedOrgans at RiskRadiotherapy Planning, Computer-AssistedRectal NeoplasmsRadiotherapy, ConformalOrgan Sparing TreatmentsAdenocarcinomaHumansFemaleFeasibility StudiesRadiotherapy DosageRetrospective StudiesMiddle AgedAged

Stichwörter der Autor:innen

3D‐CRTIMRTdosimetric analysisphotonradiation treatmentrectal cancersexual organs at risk

Autor:innen und Institutionen

  • Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Division of Anatomy, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
  • Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Radiation Oncology, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Margaret H Downes, Vishruta Dumane

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Downes, M. H., Olsen, V., Williams, A., Sheu, R., Thor, M., Greenwald, L., Dumane, V., Hsieh, K., Ali, A., Morgan, O., Buckstein, M., & Marshall, D. C. (2025). A feasibility study of sexual organ‐dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three‐dimensional conformal radiation therapy. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70394

Vancouver

Downes MH, Olsen V, Williams A, Sheu R, Thor M, Greenwald L, et al. A feasibility study of sexual organ‐dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three‐dimensional conformal radiation therapy. Journal of Applied Clinical Medical Physics. 2025. doi:10.1002/acm2.70394

BibTeX
@article{Downes2025,
  author = {Downes, Margaret H and Olsen, Victoria and Williams, Andre and Sheu, Rendi and Thor, Maria and Greenwald, Lucy and Dumane, Vishruta and Hsieh, Kristin and Ali, Ayesha and Morgan, Orly and Buckstein, Michael and Marshall, Deborah C},
  title = {A feasibility study of sexual organ‐dose sparing volumetric modulated arc therapy in female low rectal cancer patients treated with three‐dimensional conformal radiation therapy},
  journal = {Journal of Applied Clinical Medical Physics},
  year = {2025},
  doi = {10.1002/acm2.70394}
}
Kostenlos starten →